These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18541522)

  • 1. Catestatin is a novel endogenous peptide that regulates cardiac function and blood pressure.
    Mahapatra NR
    Cardiovasc Res; 2008 Dec; 80(3):330-8. PubMed ID: 18541522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension.
    Rao F; Wen G; Gayen JR; Das M; Vaingankar SM; Rana BK; Mahata M; Kennedy BP; Salem RM; Stridsberg M; Abel K; Smith DW; Eskin E; Schork NJ; Hamilton BA; Ziegler MG; Mahata SK; O'Connor DT
    Circulation; 2007 May; 115(17):2271-81. PubMed ID: 17438154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromogranin A: a surprising link between granule biogenesis and hypertension.
    Kim T; Loh YP
    J Clin Invest; 2005 Jul; 115(7):1711-3. PubMed ID: 16007250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells.
    Lee JC; Taylor CV; Gaucher SP; Toneff T; Taupenot L; Yasothornsrikul S; Mahata SK; Sei C; Parmer RJ; Neveu JM; Lane WS; Gibson BW; O'Connor DT; Hook VY
    Biochemistry; 2003 Jun; 42(23):6938-46. PubMed ID: 12795588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte migration: a novel effect and signaling pathways of catestatin.
    Egger M; Beer AG; Theurl M; Schgoer W; Hotter B; Tatarczyk T; Vasiljevic D; Frauscher S; Marksteiner J; Patsch JR; Schratzberger P; Djanani AM; Mahata SK; Kirchmair R
    Eur J Pharmacol; 2008 Nov; 598(1-3):104-11. PubMed ID: 18834877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A(344-364)): identification of amino acid residues crucial for activity.
    Mahata SK; Mahata M; Wakade AR; O'Connor DT
    Mol Endocrinol; 2000 Oct; 14(10):1525-35. PubMed ID: 11043569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.
    Mahata SK; O'Connor DT; Mahata M; Yoo SH; Taupenot L; Wu H; Gill BM; Parmer RJ
    J Clin Invest; 1997 Sep; 100(6):1623-33. PubMed ID: 9294131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters.
    Mahapatra NR; Mahata M; Mahata SK; O'Connor DT
    J Hypertens; 2006 May; 24(5):895-904. PubMed ID: 16612252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis and validation of traits associated with a single nucleotide polymorphism Gly364Ser in catestatin using humanized chromogranin A mouse models.
    Mir SA; Zhang K; Milic M; Gu Y; Rieg T; Ziegler M; Vaingankar SM
    J Hypertens; 2016 Jan; 34(1):68-78. PubMed ID: 26556564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension.
    O'Connor DT; Kailasam MT; Kennedy BP; Ziegler MG; Yanaihara N; Parmer RJ
    J Hypertens; 2002 Jul; 20(7):1335-45. PubMed ID: 12131530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamine secretory vesicle stimulus-transcription coupling in vivo. Demonstration by a novel transgenic promoter/photoprotein reporter and inhibition of secretion and transcription by the chromogranin A fragment catestatin.
    Mahata SK; Mahapatra NR; Mahata M; Wang TC; Kennedy BP; Ziegler MG; O'Connor DT
    J Biol Chem; 2003 Aug; 278(34):32058-67. PubMed ID: 12799369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A.
    Preece NE; Nguyen M; Mahata M; Mahata SK; Mahapatra NR; Tsigelny I; O'Connor DT
    Regul Pept; 2004 Apr; 118(1-2):75-87. PubMed ID: 14759560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catestatin attenuates the effects of intrathecal nicotine and isoproterenol.
    Gaede AH; Lung MS; Pilowsky PM
    Brain Res; 2009 Dec; 1305():86-95. PubMed ID: 19785998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The catecholamine release-inhibitory "catestatin" fragment of chromogranin a: naturally occurring human variants with different potencies for multiple chromaffin cell nicotinic cholinergic responses.
    Mahata SK; Mahata M; Wen G; Wong WB; Mahapatra NR; Hamilton BA; O'Connor DT
    Mol Pharmacol; 2004 Nov; 66(5):1180-91. PubMed ID: 15326220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catestatin: A Master Regulator of Cardiovascular Functions.
    Mahata SK; Kiranmayi M; Mahapatra NR
    Curr Med Chem; 2018; 25(11):1352-1374. PubMed ID: 28443506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo.
    Kennedy BP; Mahata SK; O'Connor DT; Ziegler MG
    Peptides; 1998; 19(7):1241-8. PubMed ID: 9786174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The catecholamine release-inhibitory peptide catestatin (chromogranin A344-363) modulates myocardial function in fish.
    Imbrogno S; Garofalo F; Cerra MC; Mahata SK; Tota B
    J Exp Biol; 2010 Nov; 213(Pt 21):3636-43. PubMed ID: 20952611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin.
    Biswas N; Vaingankar SM; Mahata M; Das M; Gayen JR; Taupenot L; Torpey JW; O'Connor DT; Mahata SK
    Endocrinology; 2008 Feb; 149(2):749-57. PubMed ID: 17991725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catestatin: a multifunctional peptide from chromogranin A.
    Mahata SK; Mahata M; Fung MM; O'Connor DT
    Regul Pept; 2010 Jun; 162(1-3):33-43. PubMed ID: 20116404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of chromogranin A on catecholamine release: molecular modeling of the catestatin region reveals a beta-strand/loop/beta-strand structure secured by hydrophobic interactions and predictive of activity.
    Tsigelny I; Mahata SK; Taupenot L; Preece NE; Mahata M; Khan I; Parmer RJ; O'Connor DT
    Regul Pept; 1998 Oct; 77(1-3):43-53. PubMed ID: 9809795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.